These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21531289)

  • 1. In vivo evaluation of carbon-11-labelled non-sarcosine-based glycine transporter 1 inhibitors in mice and conscious monkeys.
    Toyohara J; Ishiwata K; Sakata M; Wu J; Nishiyama S; Tsukada H; Hashimoto K
    Nucl Med Biol; 2011 May; 38(4):517-27. PubMed ID: 21531289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.
    Hashimoto K; Fujita Y; Ishima T; Chaki S; Iyo M
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):414-21. PubMed ID: 17804206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
    Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
    Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcosine based indandione hGlyT1 inhibitors.
    Thomson CG; Duncan K; Fletcher SR; Huscroft IT; Pillai G; Raubo P; Smith AJ; Stead D
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1388-91. PubMed ID: 16321523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
    Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
    Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acylglycinamides as inhibitors of glycine transporter type 1.
    Blunt R; Porter R; Johns A; Nash D; Puckey G; Wyman P; Herdon H; Teague S; Hadden V; Fontana S; Gordon L
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6176-9. PubMed ID: 21889344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms.
    Harsing LG; Timar J; Szabo G; Udvari S; Nagy KM; Marko B; Zsilla G; Czompa A; Tapolcsanyi P; Kocsis A; Matyus P
    Curr Pharm Des; 2015; 21(17):2291-303. PubMed ID: 25578890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and in vivo evaluation of [11C]-labelled pyrrole-2-carboxamide derivates as novel radioligands for PET imaging of monoamine oxidase A.
    De Bruyne S; La Regina G; Staelens S; Wyffels L; Deleye S; Silvestri R; De Vos F
    Nucl Med Biol; 2010 May; 37(4):459-67. PubMed ID: 20447558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1.
    Gunn RN; Murthy V; Catafau AM; Searle G; Bullich S; Slifstein M; Ouellet D; Zamuner S; Herance R; Salinas C; Pardo-Lozano R; Rabiner EA; Farre M; Laruelle M
    Synapse; 2011 Dec; 65(12):1319-32. PubMed ID: 21688322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and evaluation of [11C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography.
    Passchier J; Gentile G; Porter R; Herdon H; Salinas C; Jakobsen S; Audrain H; Laruelle M; Gunn RN
    Synapse; 2010 Jul; 64(7):542-9. PubMed ID: 20196141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of GlyT1 inhibitors with improved pharmacokinetic properties.
    Wolkenberg SE; Zhao Z; Wisnoski DD; Leister WH; O'Brien J; Lemaire W; Williams DL; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Gibson C; Ma BK; Polsky-Fisher SL; Lindsley CW; Hartman GD
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1492-5. PubMed ID: 19181525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates.
    Castner SA; Murthy NV; Ridler K; Herdon H; Roberts BM; Weinzimmer DP; Huang Y; Zheng MQ; Rabiner EA; Gunn RN; Carson RE; Williams GV; Laruelle M
    Neuropsychopharmacology; 2014 Nov; 39(12):2742-9. PubMed ID: 24487737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment.
    Tanabe M; Takasu K; Yamaguchi S; Kodama D; Ono H
    Anesthesiology; 2008 May; 108(5):929-37. PubMed ID: 18431130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK-6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracers.
    Hamill TG; Eng W; Jennings A; Lewis R; Thomas S; Wood S; Street L; Wisnoski D; Wolkenberg S; Lindsley C; Sanabria-Bohórquez SM; Patel S; Riffel K; Ryan C; Cook J; Sur C; Burns HD; Hargreaves R
    Synapse; 2011 Apr; 65(4):261-70. PubMed ID: 20687108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of the GlyT-1 glycine transporter using two novel radioligands.
    Herdon HJ; Roberts JC; Coulton S; Porter RA
    Neuropharmacology; 2010 Nov; 59(6):558-65. PubMed ID: 20691713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
    Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
    Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis and SAR of 2-arylsulfanylphenyl-1-oxyalkylamino acids as GlyT-1 inhibitors.
    Smith G; Mikkelsen G; Eskildsen J; Bundgaard C
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3981-4. PubMed ID: 16725323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
    Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
    J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.